Vertex Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

20.12.24	Vertex' Trikafta Gets Expanded FDA Approval For Cystic Fibrosis Treatment (RTTNews)
20.12.24	Vertex's Cystic Fibrosis Drug Alyftrek Gets FDA Approval (RTTNews)
19.12.24	Vertex Stock Falls After Release Of Phase 2 Results For Suzetrigine Study (RTTNews)
04.11.24	Vertex Pharmaceuticals Inc. Q3 Profit Increases, Beats Estimates (RTTNews)
26.09.24	Vertex Says Health Canada Accepts NDS For Triple Combination To Treat Cystic Fibrosis (RTTNews)
26.09.24	Health Canada Oks Vertex's CASGEVY, First CRISPR/Cas9 Gene-Edited Therapy For Sickle Cell Disease (RTTNews)
04.08.24	Weekly Biotech Buzz: FGEN Cuts Jobs, FDA OKs ADAP's Groundbreaking Cell Therapy, ME Rebuffs CEO Bid (RTTNews)
01.08.24	Vertex Pharmaceuticals Inc. Q2 Earnings Summary (RTTNews)
15.07.24	Vertex Pharma Announces Expanded Approval Of TRIKAFTA By Health Canada - Quick Facts (RTTNews)
02.07.24	Vertex Pharma: Vanza Triple Granted Priority Review - Quick Facts (RTTNews)
07.06.24	These Biotech Stocks Hit New Highs, Did You Reap The Rewards? (RTTNews)
06.05.24	Vertex Pharmaceuticals Inc. Q1 Profit Increases, beats estimates (RTTNews)
23.04.24	Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem (RTTNews)
10.04.24	Vertex Pharmaceuticals To Buy Alpine Immune Sciences For $4.9 Bln (RTTNews)
01.04.24	Vertex's NDS For Exagamglogene Autotemcel Gets Health Canada's Priority Review Acceptance (RTTNews)
01.04.24	Vertex Advances Inaxaplin Into Phase 2/3 Trial To Treat APOL1-Mediated Kidney Disease (RTTNews)
21.03.24	Vertex Gets FDA Nod Of IND For VX-407 For Autosomal Dominant Polycystic Kidney Disease (RTTNews)
23.02.24	Vertex's Kalydeco Gets CHMP Positive Opinion For Label Expansion To Cystic Fibrosis In Infants (RTTNews)
13.02.24	Vertex : EU Okays Casgevy For Sickle Cell Disease & Transfusion-Dependent Beta Thalassemia Treatment (RTTNews)
05.02.24	Vertex Pharmaceuticals Inc. Q4 Profit Increases, beats estimates (RTTNews)
30.01.24	Vertex's Experimental Pain Drug Meets Phase 3 Primary Goal (RTTNews)
15.12.23	Vertex Receives CHMP Positive Opinion For The First CRISPR/Cas9 Gene-Edited Therapy CASGEVY (RTTNews)
13.12.23	Vertex Announces Positive Results From Phase 2 Study Of VX-548 In Diabetic Peripheral Neuropathy (RTTNews)
30.11.23	Biotech Stocks Facing FDA Decision In December 2023 (RTTNews)
16.11.23	First Regulatory Authorization For A CRISPR-based Gene-editing Therapy (RTTNews)
06.11.23	Vertex Pharmaceuticals Inc. Q3 Profit Increases, beats estimates (RTTNews)
01.08.23	Vertex Pharmaceuticals Inc. Q2 Profit Increases, beats estimates (RTTNews)
26.06.23	Vertex Pharma, Lonza Collaborate To Build Manufacturing Facility For Type 1 Diabetes Cell Therapies (RTTNews)
01.05.23	Vertex Pharmaceuticals Inc. Q1 Profit Decreases, but beats estimates (RTTNews)
10.04.23	Vertex : Canada Approves PrORKAMBI For Treatment Of Cystic Fibrosis In Children Ages 1 To <2 Year (RTTNews)
27.03.23	Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology (RTTNews)
09.03.23	Vertex Pharma: FDA Clears IND Application For VX-264; Plans To Begin Phase 1/2 Trial In H1 (RTTNews)
07.02.23	Vertex Pharmaceuticals Inc. Reports Rise In Q4 Profit (RTTNews)
08.12.22	Vertex, Entrada To Develop Endosomal Escape Vehicle Therapeutics For Myotonic Dystrophy Type 1 (RTTNews)
17.11.22	Form 4 875320 (RSS)
03.11.22	Form 4 875320 (RSS)
28.10.22	Form 10-Q 875320 (RSS)
27.10.22	Vertex Pharmaceuticals Inc. Q3 Profit Advances (RTTNews)
27.10.22	Form 8-K 875320 (RSS)
26.10.22	Form 4 875320 (RSS)
21.09.22	Initial statement of beneficial ownership of securities (RSS)
04.08.22	Vertex Pharmaceuticals Inc. Reveals Rise In Q2 Bottom Line (RTTNews)
04.08.22	Vertex Pharmaceuticals Lifts FY22 Product Revenue Outlook (RTTNews)
21.07.22	Statement of changes in beneficial ownership of securities (RSS)
11.07.22	Vertex Pharma To Acquire ViaCyte For $320 Mln In Cash (RTTNews)
05.07.22	Vertex Pharma Says FDA Lifts Clinical Hold On Phase 1/2 Trial Of VX-880 To Treat Type 1 Diabetes (RTTNews)
08.06.22	Vertex Pharma: FDA Grants Inaxaplin Breakthrough Therapy Designation (RTTNews)
18.05.22	Initial statement of beneficial ownership of securities (RSS)
05.05.22	Vertex Pharmaceuticals Inc. Q1 Profit Increases, beats estimates (RTTNews)
05.05.22	Form 8-K 875320 (RSS)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Börse New York in Grün: So steht der NASDAQ 100 aktuell
20.12.24		Minuszeichen in London: FTSE 100 schwächelt zum Ende des Freitagshandels
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Börse New York in Grün: So steht der NASDAQ 100 aktuell

20.12.24

Minuszeichen in London: FTSE 100 schwächelt zum Ende des Freitagshandels

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten